September 26, 2019
RegMed Investors’ (RMi) closing bell: the roller-coaster rolls down
September 17, 2019
RegMed Investors’ (RMi) pre-open: is the cell and gene therapy sector upside sustainable?
September 13, 2019
RegMed Investors’ (RMi) closing bell: value was torpedoed by electronic trading
September 4, 2019
RegMed Investors’ (RMi) pre-open: riding the roller-coaster
September 3, 2019
RegMed Investors’ (RMi) closing bell: Cell and gene therapy equities fell, the first trading day of a historically tough month
August 16, 2019
RegMed Investors’ (RMi) closing bell: a whacky week as the volatility index of 19.13, -2.71 or -12.80%
August 5, 2019
Regenerative Medicine Earnings Scorecard - Q2/19 - to date
August 2, 2019
RegMed Investors’ (RMi) closing bell: the session and the week’s review
July 25, 2019
RegMed Investors’ (RMi) pre-open: sit, seek sanctuary or lock-in a de-risked position pre-earnings release?
July 11, 2019
RegMed Investors’ (RMi) closing bell: Insight about share pricing is about understanding perception
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2025 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.